What is the address of SOINS INFIRMIERS KARINE YANSSENS?

The registered office of SOINS INFIRMIERS KARINE YANSSENS is located at Rue Haute(ST) 29, 6182 Courcelles.

Is SOINS INFIRMIERS KARINE YANSSENS still active?

Yes. According to the CBE (19 September 2026) SOINS INFIRMIERS KARINE YANSSENS is active, legal situation “Normale toestand”, started on 24 December 2021.

Is SOINS INFIRMIERS KARINE YANSSENS registered on Peppol?

No, SOINS INFIRMIERS KARINE YANSSENS is currently not registered on the Peppol network.

What is the enterprise number of SOINS INFIRMIERS KARINE YANSSENS?

The enterprise number of SOINS INFIRMIERS KARINE YANSSENS is BE0779338382.

When was SOINS INFIRMIERS KARINE YANSSENS founded?

SOINS INFIRMIERS KARINE YANSSENS was founded on 24 December 2021.

Who are the directors of SOINS INFIRMIERS KARINE YANSSENS?

According to the 2025 annual accounts, the directors of SOINS INFIRMIERS KARINE YANSSENS are: Karine YANSSENS.

Is SOINS INFIRMIERS KARINE YANSSENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SOINS INFIRMIERS KARINE YANSSENS make in 2025?

SOINS INFIRMIERS KARINE YANSSENS posted a profit after taxes of € 33,201 in financial year 2025.

What is the revenue of SOINS INFIRMIERS KARINE YANSSENS?

As a small company, SOINS INFIRMIERS KARINE YANSSENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 94,047.

SOINS INFIRMIERS KARINE YANSSENS (Private Limited)

Dossier SOINS INFIRMIERS KARINE YANSSENS, printed on 19 September 2026 from databakkes.be/en/0779338382/soins-infirmiers-karine-yanssens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SOINS INFIRMIERS KARINE YANSSENS from Courcelles, company number BE0779338382, closed financial year 2025 with a result of € 33,201 after tax. For that financial year SOINS INFIRMIERS KARINE YANSSENS recorded a gross margin of € 94,047 and equity of € 195,642. Compared with financial year 2024, the result moved from € 50,888 to € 33,201. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Healthy

€ 195,642

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 33,201

▼ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,815

▲ 139% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 33,201 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 569

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,631

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 24,369

▼ 48% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,269 Gross margin 2022: € 123,269 First fiscal year in the series	€ 88,936 Gross margin 2023: € 88,936 ▼ 28% vs 2022 (€ 123,269) Unfavourable step	€ 120,649 Gross margin 2024: € 120,649 ▲ 36% vs 2023 (€ 88,936) Favourable step	€ 94,047 Gross margin 2025: € 94,047 ▼ 22% vs 2024 (€ 120,649) Unfavourable step	▼ 22%
Profit after taxes	€ 88,890 Profit after taxes 2022: € 88,890 First fiscal year in the series	€ 52,364 Profit after taxes 2023: € 52,364 ▼ 41% vs 2022 (€ 88,890) Unfavourable step	€ 50,888 Profit after taxes 2024: € 50,888 ▼ 3% vs 2023 (€ 52,364) Unfavourable step	€ 33,201 Profit after taxes 2025: € 33,201 ▼ 35% vs 2024 (€ 50,888) Unfavourable step	▼ 35%
Equity	€ 92,390 Equity 2022: € 92,390 First fiscal year in the series	€ 144,754 Equity 2023: € 144,754 ▲ 57% vs 2022 (€ 92,390) Favourable step	€ 195,642 Equity 2024: € 195,642 ▲ 35% vs 2023 (€ 144,754) Favourable step	€ 195,642 Equity 2025: € 195,642 Unchanged (€ 195,642) Unchanged
Total debts	€ 36,925 Total debts 2022: € 36,925 First fiscal year in the series	€ 193,426 Total debts 2023: € 193,426 ▲ € 156,501 vs 2022 (€ 36,925) Unfavourable step	€ 96,587 Total debts 2024: € 96,587 ▼ 50% vs 2023 (€ 193,426) Favourable step	€ 60,201 Total debts 2025: € 60,201 ▼ 38% vs 2024 (€ 96,587) Favourable step	▼ 38%
Cash	€ 2,524 Cash 2022: € 2,524 First fiscal year in the series	€ 4,200 Cash 2023: € 4,200 ▲ 66% vs 2022 (€ 2,524) Favourable step	€ 7,463 Cash 2024: € 7,463 ▲ 78% vs 2023 (€ 4,200) Favourable step	€ 17,815 Cash 2025: € 17,815 ▲ 139% vs 2024 (€ 7,463) Favourable step	▲ 139%
Retained profit	€ 88,890 Retained profit 2022: € 88,890 First fiscal year in the series	€ 141,254 Retained profit 2023: € 141,254 ▲ 59% vs 2022 (€ 88,890) Favourable step	€ 192,142 Retained profit 2024: € 192,142 ▲ 36% vs 2023 (€ 141,254) Favourable step	€ 192,142 Retained profit 2025: € 192,142 Unchanged (€ 192,142) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 33,201 Dividend 2025: € 33,201 Unchanged (€ 0) Unchanged
Balance sheet total	€ 129,315 Balance sheet total 2022: € 129,315 First fiscal year in the series	€ 338,180 Balance sheet total 2023: € 338,180 ▲ 162% vs 2022 (€ 129,315) Unchanged	€ 292,228 Balance sheet total 2024: € 292,228 ▼ 14% vs 2023 (€ 338,180) Unchanged	€ 255,843 Balance sheet total 2025: € 255,843 ▼ 12% vs 2024 (€ 292,228) Unchanged	▼ 12%

Key figures of SOINS INFIRMIERS KARINE YANSSENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to SOINS INFIRMIERS KARINE YANSSENS?

What happened at SOINS INFIRMIERS KARINE YANSSENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 33,201 (▼ 35% vs 2024). Source: NBB ↗
2021 Karine YANSSENS became a director. NBB
Dec 24, 2021 Start of the company according to the CBE. KBO

In short

From € 88,890 profit in 2022 to € 33,201 profit in 2025.

Paid € 76,611 in corporate taxes since 2022.

Best year ever: 2022, with € 88,890 profit.

Paid out € 33,201 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SOINS INFIRMIERS KARINE YANSSENS? We notify you, reason included.

Follow SOINS INFIRMIERS KARINE YANSSENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Karine YANSSENS

SOINS INFIRMIERS KARINE YANSSENS

Behind SOINS INFIRMIERS KARINE YANSSENS is Karine YANSSENS.

See the full network in the app

Directors

According to the 2025 annual accounts

Karine YANSSENS

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Haute(ST) 29

6182 Courcelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0779.338.382
VAT number: BE 0779.338.382
Registered office: Rue Haute(ST) 29, 6182 Courcelles
Names & denominations: SOINS INFIRMIERS KARINE YANSSENS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗